BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 111704
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.111704
Table 1 Baseline data of participants, n (%)
Indicators
Observation group (n = 65)
Control group (n = 50)
t/χ2
P value
Age (years) (mean ± SD)56.06 ± 11.2659.92 ± 10.791.8560.066
Sex0.0700.791
Male38 (58.46)28 (56.00)
Female27 (41.54)22 (44.00)
Tumor classification0.6060.895
Gastric cancer18 (27.69)15 (30.00)
Rectal cancer16 (24.62)13 (26.00)
Colon cancer14 (21.54)12 (24.00)
Pancreatic cancer17 (26.15)10 (20.00)
Acute Physiology and Chronic Health Evaluation II (points) (mean ± SD)27.18 ± 6.3428.18 ± 6.460.8320.407
Karnofsky Performance Status functional status score (points) (mean ± SD)39.58 ± 11.3240.40 ± 14.040.3470.729
Previous chemotherapy treatments0.6450.422
No20 (30.77)12 (24.00)
Yes45 (69.23)38 (76.00)


Write to the Help Desk